Featured Articles

July 15, 2021

Research on dapivirine ring use among adolescent girls and young women presented at IAS 2021

July 15, 2021—Interim results from REACH, an open-label study of IPM’s monthly dapivirine ring as well as of daily oral PrEP, are being presented at the 11th IAS Conference on HIV Science (IAS 2021... More »

March 17, 2021

Dapivirine Vaginal Ring Added to WHO Clinical Guidelines as HIV Prevention Choice for Women

March 17, 2021—The World Health Organization (WHO) has updated its clinical guidelines on antiretroviral (ARV) drugs for HIV prevention to include a recommendation for IPM’s monthly dapivirine... More »

March 08, 2021

By Women, For Women: An International Women's Day Story Collection

March 8, 2021—Happy International Women's Day! Here at IPM, women are at the core of everything we do—from developing woman-centered and woman-controlled HIV prevention and other sexual and... More »

March 05, 2021

Hope for the Future: My Experience With the Dapivirine Ring

March 5, 2021We spoke to Akhona Gxarisa, a 27-year-old primary school teacher in Cape Town, South Africa who participated in the Ring Study and DREAM. She tells us about her experience in the... More »

February 01, 2021

Dapivirine ring OLE study results featured in The Lancet HIV

February 1, 2021—Primary results from two open-label extension studies (OLEs) of IPM’s dapivirine vaginal ring, DREAM and HOPE, are featured in The Lancet HIV’s February 2021 issue. The publications... More »